Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 9/20 | 0.68 |
| ▸ | CA2 | P00918 | 9/20 | 0.68 |
| ▸ | CA9 | Q16790 | 8/20 | 0.68 |
| ▸ | CA12 | O43570 | 5/20 | 0.68 |
| ▸ | CA7 | P43166 | 5/20 | 0.68 |
| ▸ | TSHR | P16473 | 2/20 | 0.68 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.51 |
| ▸ | PDIA6 | Q15084 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TTK | P33981 | 1/20 | 0.47 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.47 |
| ▸ | TLR4 | O00206 | 1/20 | 0.47 |
| ▸ | TLR2 | O60603 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29469874 | 0.85 | CA1 (0.62) | CA1CA2CA9CA12CA7 | |
| SCHEMBL5610159 | 0.85 | CA1 (0.62) | CA1CA2CA9CA12CA7 | |
| SCHEMBL4491901 | 0.84 | KAT6A (0.51) | CA1CA2CA9CA12CA7 | |
| SCHEMBL615392 | 0.81 | CA2 (1.00) | CA1CA2CA9CA12CA7 | |
| SCHEMBL31195081 | 0.79 | TSHR (0.54) | CA1CA2CA9CA12CA7 | |
| SCHEMBL4397448 | 0.78 | TSHR (0.63) | TSHRTLR4TLR2LTA4HTHRB | |
| SCHEMBL1376263 | 0.78 | CA2 (0.93) | CA1CA2CA9CA12CA7 | |
| SCHEMBL3052170 | 0.78 | CA1 (0.43) | CA1CA2CA9CA12CA7 | |
| SCHEMBL4872330 | 0.78 | CA1 (0.50) | CA1CA2CA9CA12CA7 | |
| SCHEMBL10822914 | 0.77 | CA2 (0.90) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090207712-A1 | OPTICAL RECORDING MEDIUM AND METHOD OF RECORDING VISIBLE INFORMATION | FUJIFILM CORPORATION (JP) | 2009-08-20 | — | — | US | disclosed |
| EP-2003644-A9 | OPTICAL RECORDING MEDIUM AND VISIBLE INFORMATION RECORDING METHOD | Fujifilm Corporation (JP) | 2009-04-15 | — | — | EP | disclosed |
| US-20090058982-A1 | OPTICAL RECORDING MEDIUM AND METHOD OF RECORDING VISIBLE INFORMATION | FUJIFILM CORPORATION (JP) | 2009-03-05 | — | — | US | disclosed |
| US-20090022047-A1 | OPTICAL RECORDING MEDIUM AND METHOD OF RECORDING VISIBLE INFORMATION | FUJIFILM CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-2003644-A2 | OPTICAL RECORDING MEDIUM AND VISIBLE INFORMATION RECORDING METHOD | Fujifilm Corporation (JP) | 2008-12-17 | — | — | EP | disclosed |
| US-20070265281-A1 | Organic Compounds and Their Uses | COTTENS SYLVAIN | 2007-11-15 | — | — | US | disclosed |
| EP-0671660-B1 | Lead-frame forming material | FUJI PHOTO FILM CO LTD (JP) | 2001-10-17 | — | — | EP | disclosed |
| US-5670293-A | LIGHT SENSITIVE MATERIAL WITH COPPER OR NICKEL ALLOYS, DRYING A PHOTOSENSITIVE LAYER AND WINDING THE COATED WEB INTO STRIPS AND STACKING | FUJI PHOTO FILM CO., LTD. (JP) | 1997-09-23 | — | — | US | disclosed |
| EP-0671660-A2 | Lead-frame forming material | FUJI PHOTO FILM CO., LTD. (JP) | 1995-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265281-A1 | Organic Compounds and Their Uses | OAT, OTC, AOX1 | CA1 2516/4885CA2 1716/4885CA9 605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.